返回
Developing a value proposition for high-sensitivity troponin testing
DOI:10.1016/j.cca.2017.12.007.png)
摘要
En 中文
Laboratories are looking for ways that they can identify and deliver value through their service rather than just provide high quality test results. One way to demonstrate value has been described in the form of a value proposition where the application of a laboratory test is described explicitly in terms of the process of care and the patient outcomes. We have applied this concept to the use of high sensitivity troponin assays for the assessment of patients with suspected acute coronary syndrome. From a previously described framework we use a checklist to describe the various steps in the complete intervention or clinical pathway, demonstrating how the test should be used, highlighting key evidence in the literature that supports the intervention and list some of the measures which can be used to assess how well the intervention is being adopted and implemented. While the value proposition concept is based on the foundations of evidence based medicine it also requires collaboration between the laboratory and other stakeholders including clinicians to ensure that appropriate resources are applied across the complete clinical pathway in order to ensure its effectiveness.
Keyword:
Diagnostics
Value proposition
Troponin
Acute coronary syndrome
Health economics
Cost-effectiveness
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
2.9
论文数:
1.6W
被引数:
2.1W
机构
引用论文
Case definitions for acute coronary heart disease in epidemiology and clinical research studies - A statement from the AHA council on epidemiology and prevention; AHA Statistics Committee; World Heart Federation Council on epidemiology and prevention; the European Society of Cardiology working group on epidemiology and prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute
CIRCULATION
IF38.6
Current Evidence and Future Perspectives on the Effective Practice of Patient-Centered Laboratory Medicine
CLINICAL CHEMISTRY
IF6.3
State-of-the-Art Evaluation of Emergency Department Patients Presenting With Potential Acute Coronary Syndromes
CIRCULATION
IF38.6
What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department? A clinical survey从急诊科出院后不久,胸痛患者发生主要不良心脏事件的可接受风险是多少?临床调查
Leveraging the real value of laboratory medicine with the value proposition
CLINICA CHIMICA ACTA
IF2.9

